Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David A. Proia
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association With Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
Hormones and Cancer
Oncology
Cancer Research
Endocrinology
Autonomic Systems
Endocrine
Metabolism
Diabetes
Related publications
Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to Decitabine
Journal of Clinical Investigation
Medicine
Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
The Results of a Study of Chemotherapy With Bevacizumab, Oxaliplatin and Paclitaxel in Patients With Metastatic Triple Negative Breast Cancer
Malignant tumours
Tumor Tissue microRNA Expression in Association With Triple-Negative Breast Cancer Outcomes
Breast Cancer Research and Treatment
Cancer Research
Oncology
Cisplatin Versus Carboplatin in Combination With Paclitaxel as Neoadjuvant Regimen for Triple Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Androgen Receptor-Positive, Triple-Negative Breast Cancer
Cancer
Cancer Research
Oncology
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
